NO924525L - Tri-arginininsuliner - Google Patents

Tri-arginininsuliner

Info

Publication number
NO924525L
NO924525L NO92924525A NO924525A NO924525L NO 924525 L NO924525 L NO 924525L NO 92924525 A NO92924525 A NO 92924525A NO 924525 A NO924525 A NO 924525A NO 924525 L NO924525 L NO 924525L
Authority
NO
Norway
Prior art keywords
arginininsuliner
tri
Prior art date
Application number
NO92924525A
Other languages
English (en)
Norwegian (no)
Other versions
NO924525D0 (no
Inventor
James Arthur Hoffmann
Peter Karl Lambooy
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO924525D0 publication Critical patent/NO924525D0/no
Publication of NO924525L publication Critical patent/NO924525L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92924525A 1991-11-26 1992-11-24 Tri-arginininsuliner NO924525L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80116391A 1991-11-26 1991-11-26

Publications (2)

Publication Number Publication Date
NO924525D0 NO924525D0 (no) 1992-11-24
NO924525L true NO924525L (no) 1993-05-27

Family

ID=25180362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924525A NO924525L (no) 1991-11-26 1992-11-24 Tri-arginininsuliner

Country Status (17)

Country Link
US (2) US5491216A (cs)
EP (1) EP0544466A1 (cs)
JP (1) JP3304442B2 (cs)
KR (1) KR930009591A (cs)
CN (1) CN1072723A (cs)
AU (1) AU2857692A (cs)
BR (1) BR9204542A (cs)
CA (1) CA2083360A1 (cs)
CZ (1) CZ342492A3 (cs)
FI (1) FI925343L (cs)
HU (2) HU9203688D0 (cs)
IL (1) IL103849A0 (cs)
MX (1) MX9206724A (cs)
NO (1) NO924525L (cs)
NZ (1) NZ245170A (cs)
TW (1) TW224471B (cs)
ZA (1) ZA928916B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3778936B2 (ja) * 1995-02-20 2006-05-24 アムラド・オペレイションズ・プロプライエタリー・リミテッド インシュリン依存性糖尿病(iddm)患者に作用する免疫反応および免疫治療分子
PT821006E (pt) * 1996-07-26 2004-09-30 Aventis Pharma Gmbh Derivados de insulina com ligacao a zinco aumentada
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
WO2001072323A2 (en) 2000-03-24 2001-10-04 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
JP2005519041A (ja) * 2001-12-20 2005-06-30 イーライ・リリー・アンド・カンパニー 長期作用を備えたインスリン分子
US20060217290A1 (en) * 2003-04-29 2006-09-28 Kohn Wayne D Insulin analogs having protracted time action
WO2007081824A2 (en) * 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
PT2074141T (pt) * 2006-09-22 2016-11-10 Novo Nordisk As Análogos de insulina resistentes a proteases
EP2074140B8 (en) 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
BRPI0910348B1 (pt) 2008-03-18 2021-06-29 Novo Nordisk A/S Insulina estabilizada em protease acilada, composição farmacêutica compreendendo a mesma e seus usos
WO2009129250A2 (en) * 2008-04-14 2009-10-22 Case Western Reserve University Meal-time insulin analogues of enhanced stability
WO2009132129A2 (en) * 2008-04-22 2009-10-29 Case Western Reserve University Isoform-specific insulin analogues
WO2011072288A2 (en) 2009-12-11 2011-06-16 Case Western Reserve University Insulin analogues with chlorinated amino acids
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
JP2014509603A (ja) * 2011-03-15 2014-04-21 ノヴォ ノルディスク アー/エス システイン置換を含むヒトインスリン類似体およびヒトインスリン誘導体
AU2013247047A1 (en) 2012-04-11 2014-10-23 Novo Nordisk A/S Insulin formulations
CN105636979B (zh) 2013-10-07 2020-01-10 诺和诺德股份有限公司 胰岛素类似物的新衍生物
CN104017809A (zh) * 2014-06-05 2014-09-03 山东省农业科学院生物技术研究中心 改造的人Insulin蛋白表达基因及表达方法
EP3204410B1 (en) 2014-10-06 2021-01-20 Case Western Reserve University Biphasic single-chain insulin analogues
US10627415B2 (en) 2015-03-12 2020-04-21 Board Of Trustees Of Michigan State University Compositions and methods for diagnosing, monitoring, and treating an autoimmune disease
WO2017052305A1 (en) * 2015-09-24 2017-03-30 Hanmi Pharm. Co., Ltd. Method of insulin production
RU2758367C2 (ru) 2016-12-16 2021-10-28 Ново Нордиск А/С Фармацевтические композиции, содержащие инсулин

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4581165A (en) * 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US4569791A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US4569792A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
ZA877505B (en) * 1986-10-14 1989-05-30 Lilly Co Eli Process for transforming a human insulin precursor to human insulin
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5139716A (en) * 1990-02-20 1992-08-18 Loral Aerospace Corp. Method of fabricating coolable ceramic structures

Also Published As

Publication number Publication date
NO924525D0 (no) 1992-11-24
TW224471B (cs) 1994-06-01
KR930009591A (ko) 1993-06-21
FI925343A0 (fi) 1992-11-25
US5698669A (en) 1997-12-16
HU9203688D0 (en) 1993-03-29
US5491216A (en) 1996-02-13
BR9204542A (pt) 1993-06-01
CN1072723A (zh) 1993-06-02
IL103849A0 (en) 1993-04-04
HUT63457A (en) 1993-08-30
JP3304442B2 (ja) 2002-07-22
EP0544466A1 (en) 1993-06-02
JPH05286998A (ja) 1993-11-02
ZA928916B (en) 1994-05-18
CZ342492A3 (en) 1993-06-16
FI925343A7 (fi) 1993-05-27
MX9206724A (es) 1993-05-01
CA2083360A1 (en) 1993-05-27
AU2857692A (en) 1993-05-27
NZ245170A (en) 1994-07-26
FI925343L (fi) 1993-05-27

Similar Documents

Publication Publication Date Title
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
DE69219551D1 (de) Überrahmen
DE69218585D1 (de) Anzeigetafel
DE59209976D1 (de) Flaschendispenser
NO924525D0 (no) Tri-arginininsuliner
DE69219252D1 (de) Ölbehälter
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
DE69230668D1 (de) Imaginograph
ATA39792A (de) Maehwerk
DE69232673D1 (de) Tiefsttemperaturmessausrüstung
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA67791A (de) Rollski
ATA9892A (de) Formstein
BR9201945A (pt) Filatorio
DE69224122D1 (de) Kephalostat
CA68725S (fr) Mobilier-jeu
BR7100920U (pt) Kit-pipoqueira
BR9105653A (pt) Ludoquimico
BR9100759A (pt) Maca-cadeira
BR9100789A (pt) Troca-roda
BR9100957A (pt) Centrografo
BR9101513A (pt) Esfero-movel
BR9101584A (pt) Sofa-beliche